← Back to headlines
Theralase Reports Complete Response in Bladder Cancer Preclinical Study
Theralase has reported a complete response with its X-Ray-Activated Rutherrin(R) in a preclinical study for muscle-invasive bladder cancer. This finding suggests a promising new treatment approach for the disease.
13 Apr, 11:16 — 13 Apr, 11:16
